SEC CIK 1533568
Norwalk Leslie V
Reported ownership across 4 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| GMEDview stock → | 10,419 | 2026-01-08 |
| CVSview stock → | 7,376 | 2026-05-14 |
| NBIXview stock → | 2,430 | 2026-07-29 |
| CNCview stock → | 1,481.01 | 2022-03-31 |
Position History — NBIX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — NBIX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-07-29 | Option exercise (derivative) | 842 | $0.00 | 2,140 |
| 2026-07-29 | Option exercise | 842 | $139.43 | 2,430 |
| 2026-07-28 | Open-market sale | 1,250 | $182.01 | 1,588 |
| 2026-06-04 | Open-market sale | 1,250 | $168.06 | 2,838 |
| 2026-05-27 | Grant / award (derivative) | 2,624 | $0.00 | 2,624 |
| 2026-05-27 | Grant / award (derivative) | 1,284 | $0.00 | 1,284 |
| 2026-05-21 | Option exercise (derivative) | 1,659 | $0.00 | 0 |
| 2026-05-21 | Option exercise | 1,659 | $0.00 | 4,088 |
| 2026-05-12 | Open-market sale | 3,810 | $155.01 | 2,429 |
| 2025-12-16 | Open-market sale | 1,190 | $155.09 | 6,239 |
| 2025-12-15 | Option exercise (derivative) | 1,724 | $0.00 | 0 |
| 2025-12-15 | Option exercise (derivative) | 8,276 | $0.00 | 557 |
| 2025-12-15 | Option exercise | 8,276 | $92.35 | 10,705 |
| 2025-12-15 | Option exercise | 1,724 | $84.95 | 12,429 |
| 2025-12-15 | Open-market sale | 5,000 | $152.23 | 7,429 |
| 2025-05-22 | Option exercise (derivative) | 1,435 | $0.00 | 0 |
| 2025-05-22 | Option exercise | 1,435 | $0.00 | 2,429 |
| 2025-05-21 | Grant / award (derivative) | 3,305 | $0.00 | 3,305 |
| 2025-05-21 | Grant / award (derivative) | 1,659 | $0.00 | 1,659 |
| 2024-05-22 | Grant / award (derivative) | 1,435 | $0.00 | 1,435 |
| 2024-05-22 | Grant / award (derivative) | 2,982 | $0.00 | 2,982 |
| 2024-05-17 | Option exercise (derivative) | 2,100 | $0.00 | 0 |
| 2024-05-17 | Open-market sale | 1,106 | $141.82 | 994 |
| 2024-05-17 | Option exercise | 2,100 | $0.00 | 2,100 |
| 2024-02-27 | Option exercise (derivative) | 8,000 | $84.95 | 1,724 |
| 2024-02-27 | Open-market sale | 8,000 | $135.67 | 0 |
| 2024-02-27 | Option exercise | 8,000 | $84.95 | 8,000 |
| 2023-05-17 | Grant / award (derivative) | 2,100 | $0.00 | 2,100 |
| 2023-05-17 | Grant / award (derivative) | 4,290 | $0.00 | 4,290 |
| 2022-05-18 | Grant / award (derivative) | 9,724 | $0.00 | 9,724 |
| 2021-05-19 | Grant / award (derivative) | 8,833 | $0.00 | 8,833 |
| 2020-05-19 | Grant / award (derivative) | 6,018 | $0.00 | 6,018 |
| 2019-09-10 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.